Profound Medical Corp faces a setback as its stock drops over 3% in a single trading day.
Profound Medical Corp (PRN.TO) is seeing a significant decline in its stock price today, with shares falling by 3.24%. This drop comes after a period of limited media attention and concerns about the company's recent trial results.
Advertisement
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeAdvertisement
Market cap
$374.28M
52W high
$12.40
52W low
$5.23
1W change
-1.73%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 145.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+145.4% Upside
Current Price
C$10.20
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
59.3%
Annualized
90-Day Vol
53.8%
Annualized
Trend (90d)
+20.2%
Annualized drift
90d Mean
C$10.96
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$10.45 | C$8.52 – C$12.82 |
| 60 trading days | C$10.70 | C$8.01 – C$14.30 |
| 90 trading days | C$10.96 | C$7.69 – C$15.63 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should stay cautious as Profound Medical navigates challenges, especially after disappointing clinical trial outcomes.
Profound Medical Corp down 3.24% today
The stock's decline reflects investor worries about the company's recent trial results and the overall market sentiment.
Bull case
If Profound Medical can successfully recover from its recent setbacks and utilize its innovative technologies, there may be opportunities for growth and recovery in the long run.
Bear case
Ongoing issues with clinical trials and a lack of market interest could further lower stock prices, leading to more volatility and risk for investors.
Recent Performance Overview
Advertisement
Profound Medical Corp's stock has dropped by 3.24% today, closing at CA$9.87. This decline is significant for the company, which has seen limited coverage and investor interest in recent months. The market cap now stands at approximately CA$374 million, reflecting investor sentiment amid ongoing challenges.
Impact of Clinical Trials
The recent CAPTAIN trial results, which did not meet primary endpoints for robotic radical prostatectomy, have cast a shadow over Profound Medical's outlook. This setback has likely contributed to the stock's decline, as investors reassess the company's potential for growth and innovation in the medical technology sector. For more details on the trial, visit Profound Medical's press release.
Looking Ahead
As Profound Medical prepares to release its Q2 2026 financial results on August 6, investors will be closely watching for any signs of recovery or further challenges. The upcoming conference call may provide insights into the company's strategy moving forward. For updates, check out their investor relations page.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
